²ñòîð³ÿ ³íñòèòóòó
Íàö³îíàëüíèé ³íñòèòóò ôòèç³àò𳿠³
ïóëüìîíîëî㳿 ³ì Ô.Ã. ßíîâñêîãî

³äâ³äàéòå íàøó ñòîðí³êó â Facebook

 

Êë³í³êà
Êîíòàêòè

Ïåðåõîä íà òèòóëüíóþ ñòðàíèöóÏîèñê ïî ñàéòó

Óêðà¿íñüêèé ïóëüìîíîëîã³÷íèé æóðíàë

Ïðî ³íñòèòóò:

³ñòîð³ÿ,

çàãàëüí³ ïîëîæåííÿ,

ñòðóêòóðà,

íàóêîâà ä³ÿëüí³ñòü,

ïëàíè ÍÄÐ,

ë³êóâàëüíî-ä³àãíîñòè÷íà ðîáîòà,

ïðîâ³äí³ â÷åí³

Íîâèíè:

íîâèíè íà ñàéò³

Íàø³ âèäàííÿ:

"Óêðà¿íñüêèé ïóëüìîíîëîã³÷íèé æóðíàë" (ÓÏÆ),
"Óêðà¿íñüêèé õ³ì³îòåðàïåâòè÷íèé æóðíàë" (ÓÕÆ),
"Àñòìà òà àëåðã³ÿ" (ÀÀ)
"²íôóç³ÿ&Õ³ì³îòåðàï³ÿ"
(²Õ)

Îðèã³íàëüí³ ñòàòò³:

îðèã³íàëüí³ íàóêîâ³ ñòàòò³, ùî ðàí³øå íå ïóáë³êóâàëèñÿ

Íîâîââåäåííÿ:

ìåòîäè÷í³ ðåêîìåíäàö³¿, ³íôîðìàö³éí³ ëèñòè,
â³äîì÷³ ³íñòðóêö³¿,
íîâîââåäåííÿ, ìîíîãðàô³¿

Ïàòåíòè:

ïàòåíòè é àâòîðñüê³ ñâ³äîöòâà ³íñòèòóòó

Çâ³òè ïðî ÍÄÐ:

ðåôåðàòè çàê³í÷åíèõ íàóêîâî-äîñë³äíèõ ðîá³ò

ϳäãîòîâêà êàäð³â:

àñï³ðàíòóðà,

êë³í³÷íà îðäèíàòóðà,

ïëàíóâàííÿ äèñåðòàö³é,
êóðñè ³íôîðìàö³¿ ³ ñòàæóâàííÿ,

íà äîïîìîãó àñï³ðàíòó ³ çäîáóâà÷ó

Íàóêîâ³ ôîðóìè:

ðåçîëþö³¿ é çâåðíåííÿ ç'¿çä³â, êîíôåðåíö³é, íàðàä

²íôîðìàö³ÿ äëÿ ôàõ³âö³â:

îãëÿäè ë³òåðàòóðè, ñòàòèñòè÷íà ³íôîðìàö³ÿ, íîâå ó ë³êóâàíí³  òóáåðêóëüîçó òà íåñïåöèô³÷íèõ çàõâîðþâàíü ëåãåíü

²íôîðìàö³ÿ äëÿ íàñåëåííÿ:

êîðèñíà ³íôîðìàö³ÿ ïðî çàõâîðþâàííÿ ëåãåíü, ¿õ ïðîô³ëàêòèêó é ë³êóâàííÿ

Àñîö³àö³ÿ ôòèç³àòð³â ³ ïóëüìîíîëîã³â Óêðà¿íè:

îñíîâí³ çàâäàííÿ òà ä³ÿëüí³ñòü àñîö³àö³¿

Ñïåö³àë³çîâàíà â÷åíà ðàäà
Ä 26.552.01:

îïðèëþäíåííÿ äèñåðòàö³é òà â³äãóê³â îô³ö³éíèõ îïîíåíò³â

2018. - ¹ 1.
Ç̲ÑÒ / ÑÎÄÅÐÆÀÍÈÅ / CONTENTS

²ÍÔÎÐÌÀÖ²ß / INFORMATION
 

²ÍÔÎÐÌÀÖ²ÉÍÅ ÏβÄÎÌËÅÍÍß ÏÐÎ I ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÏÓËÜÌÎÍÎËÎò ÓÊÐÀ¯ÍÈ
®

FIRST NATIONAL CONGRESS OF PULMONOLOGISTS OF UKRAINE: ANNOUNCEMENT
 

 

ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ORIGINALS

 

DOI: 10.31215/2306-4927-2018-99-1-7
Þ. ². Ôåùåíêî, Ë. Î. ßøèíà, Ê. Â. Íàçàðåíêî, Ñ. Ì. Ìîñêàëåíêî, Ñ. Ã. Îï³ìàõ, Í. Ì. Ìóñ³ºíêî
ÌÎÆËÈÂÎÑÒ² IJÀÃÍÎÑÒÈÊÈ Ã²ÏÅвÍÔËßÖ²¯ ÒÀ ÅÌÔ²ÇÅÌÈ ËÅÃÅÍÜ Ó ÕÂÎÐÈÕ Ç ÏΪÄÍÀÍÈÌ ÏÅÐÅÁ²ÃÎÌ ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ ÒÀ ÕÐÎͲ×ÍÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ ÍÀ ÏÅÐÂÈÍÍÎÌÓ ÒÀ ÑÏÅÖ²À˲ÇÎÂÀÍÎÌÓ Ð²ÂÍßÕ ÍÀÄÀÍÍß ÌÅÄÈ×Íί ÄÎÏÎÌÎÃÈ

®

Yu. I. Feschenko, L. A. Iashyna, K. V. Nazarenko, S. M. Moskalenko, S. G. Opimakh, N. M. Musienko
DIAGNOSTICS OF HYPERINFLATION AND EMPHYSEMA IN PATIENTS WITH ASTHMA AND COPD OVERLAP ON THE PRIMARY AND SPECIALIZED LEVELS OF MEDICAL CARE

 

DOI: 10.31215/2306-4927-2018-99-1-14
ß. Î. Äçþáëèê, Ã. Á. Êàï³òàí, Ð. ª. Ñóõ³í, Þ. Î. Ñëºñàðåíêî, Î. Î. Ìóõ³í, Ñ. Ñ. ѳìîíîâ
ÎÏÒÈ̲ÇÀÖ²ß Ë²ÊÓÂÀÍÍß Â²ÐÓÑÍÎ-ÁÀÊÒÅвÀËÜÍί ÏÍÅÂÌÎͲ¯ Ó Â²ÉÑÜÊÎÂÎÑËÓÆÁÎÂÖ²Â, ßʲ ÌÎÁ²Ë²ÇÎÂÀͲ ÄËß ÏÐÎÕÎÄÆÅÍÍß ÑËÓÆÁÈ Â ÇÎͲ ÏÐÎÂÅÄÅÍÍß ÀÍÒÈÒÅÐÎÐÈÑÒÈ×Íί ÎÏÅÐÀÖ²¯

®

Y. A. Dziublyk, G. B. Kapitan, R. E. Sukhin, Y. A. Slesarenko, A. A. Mukhin, S. S. Simonov
OPTIMIZATION OF MANAGEMENT OF VIRAL-BACTERIAL PNEUMONIA IN RECRUITS, MOBILIZED FOR MILITARY SERVICE IN ANTI-TERRORIST OPERATION ZONE

 

DOI: 10.31215/2306-4927-2018-99-1-19
Â. Ì. Ìåëüíèê, Â. Ã. Ìàòóñåâè÷, ². Î. Íîâîæèëîâà, ². Â. Áóøóðà, À. Ì. Ïðèõîäüêî
ÅÔÅÊÒÈÂͲÑÒÜ Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÇÀ ÐÅÇÓËÜÒÀÒÀÌÈ ÂÈÊÎÍÀÍÍß «ÇÀÃÀËÜÍÎÄÅÐÆÀÂÍί Ö²ËÜÎÂί ÑÎÖ²ÀËÜÍί ÏÐÎÃÐÀÌÈ ÏÐÎÒÈIJ¯ ÇÀÕÂÎÐÞÂÀÍÍÞ ÍÀ ÒÓÁÅÐÊÓËÜÎÇ ÍÀ 2012–2016 ÐÎÊÈ»

®

V. M. Melnyk, V. G. Matusevych, I. A. Novozhylova I. V. Bushura, A. N. Prikhodko
EFFECTIVENESS OF TREATMENT OF PATIENTS ACCORDING TO “NATIONAL TARGET SOCIAL PROGRAM FOR TUBERCULOSIS CONTROL IN 2012-2016”

 

DOI: 10.31215/2306-4927-2018-99-1-23
Î. Â. Áû÷åíêî
×ÀÑÒÎÒÀ ÐÅÖÈÄÈÂÎÂ Ó ËÈÖ, ÊËÈÍÈ×ÅÑÊÈ ÈÇËÅ×ÅÍÍÛÕ ÎÒ ÑÀÐÊÎÈÄÎÇÀ ËÅÃÊÈÕ Ñ ÁÅÑÑÈÌÏÒÎÌÍÛÌ ÄÅÁÞÒÎÌ

®

O. V. Bychenko
THE RATE OF RELAPSES IN PATIENTS, CURED FROM SARCOIDOSIS WITH ASYMPTOMATIC DEBUT OF THE DISEASE

 

DOI: 10.31215/2306-4927-2018-99-1-29
Ì. À. Êðèõò³íà
ÐÈÇÈÊ ÔÎÐÌÓÂÀÍÍß ÒÐÎÌÁÎÒÈ×ÍÈÕ ÓÑÊËÀÄÍÅÍÜ Ó ÕÂÎÐÈÕ ÍÀ ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎÍ²Þ ÒÐÅÒÜί ÒÀ ×ÅÒÂÅÐÒί Ê˲Ͳ×ÍÈÕ ÃÐÓÏ

®

M. A. Krykhtina
THE RISK OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA OF CLINICAL GROUPS 3 AND 4

 

 

ÎÃËßÄÈ Ë²ÒÅÐÀÒÓÐÈ / REVIEWS

 

DOI: 10.31215/2306-4927-2018-99-1-33
Å. À. Ìåðåíêîâà
ÏÐÅÏÀÐÀÒÛ ÈÌÌÓÍÎÑÓÏÐÅÑÑÈÂÍÎÉ ÒÅÐÀÏÈÈ ÁÎËÜÍÛÕ ÈÍÒÅÐÑÒÈÖÈÀËÜÍÛÌÈ ÇÀÁÎËÅÂÀÍÈßÌÈ ËÅÃÊÈÕ

®

E. O. Merenkova
IMMUNOSUPPRESSANTS IN MANAGEMENT OF INTERSTITIAL LUNG DISEASES

 

ÇÀ ÌÀÒÅвÀËÀÌÈ Õ² ÍÀÖ²ÎÍÀËÜÍÎÃÎ ÀÑÒÌÀ-ÊÎÍÃÐÅÑÓ / MATERIALS OF THE XI NATIONAL ASTHMA CONGRESS

 

ÏÎÄÎÐÎÆ ÑÕÎÄÈÍÊÀÌÈ ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ
®

JOURNEY THROUGH THE STEPS OF BRONCHIAL ASTHMA
 

ÁÐÎÍÕÈÀËÜÍÀß ÀÑÒÌÀ È ÕÐÎÍÈ×ÅÑÊÎÅ ÎÁÑÒÐÓÊÒÈÂÍÎÅ ÇÀÁÎËÅÂÀÍÈÅ ËÅÃÊÈÕ. ÅÄÈÍÑÒÂÎ ÈÍÒÅÐÅÑΠÂÐÀ×À È ÏÀÖÈÅÍÒÀ
®

BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. UNITY OF THE DOCTOR AND PATIENT INTERESTS
 

Ì. Ì. Îñòðîâñüêèé
ÊÎÌÎÐÁ²ÄͲÑÒÜ ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ ÒÀ ÒÓÁÅÐÊÓËÜÎÇÓ ËÅÃÅÍÜ: ÒÐÓÄÍÎÙ² ˲ÊÓÂÀÍÍß À ÏÅÐÑÏÅÊÒÈÂÈ ÂÈвØÅÍÍß ÏÐÎÁËÅÌÈ

®

M. M. Ostrovsky
COMBINATION OF BRONCHIAL ASTHMA AND PULMONARY TUBERCULOSIS: DIFFICULTIES OF TREATMENT AND PERSPECTIVES FOR SOLVING THE PROBLEM
 

 

Ê˲Ͳ×Ͳ ÑÏÎÑÒÅÐÅÆÅÍÍß / CLINICAL OBSERVATIONS

 

DOI: 10.31215/2306-4927-2018-99-1-49
Ì. Ñ. Îïàíàñåíêî, ². Â. ˳ñê³íà, Î. Â. Òåðåøêîâè÷, Î. Â. Øàäð³íà, Î. Å. Êøàíîâñüêèé, Á. Ì. Êîí³ê, Ë. ². Ëåâàíäà
вÄʲÑÍÈÉ ÂÈÏÀÄÎÊ ÏΪÄÍÀÍÍß ÄÈÔÓÇÍί ÎÑÈÔ²ÊÀÖ²¯ ËÅÃÅÍÜ ² ˲ÂÎÁ²×ÍÎÃÎ Õ²ËÎÒÎÐÀÊÑÓ

®

M. S. Opanasenko, I. V. Liskina, O. V. Tereshkovych, O. V. Shadrina,O. E. Kshanovsky, B. M. Konik, L. I. Levanda
A RARE CASE OF OF DIFFUSE PULMONARY OSSIFICATION COMBINED WITH LEFT-SIDED CHYLOTHORAX

 

ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ORIGINALS

 

DOI: 10.31215/2306-4927-2018-99-1-54
Ì. ². Ëèííèê, Î. Â. Àâðàì÷óê, Ã. Â. Ñòàð³÷åê
ÇÀÑÒÎÑÓÂÀÍÍß ÊÎÌÏ'ÞÒÅÐÍί ÄÅÍÑÈÒÎÌÅÒв¯ ÄËß ÌÎͲÒÎÐÈÍÃÓ ÐÅÇÓËÜÒÀҲ ˲ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÌÎÍÎ- ÒÀ ÏÎ˲ÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

N. I. Lynnyk, O. V. Avramchuk, G. V. Starichek
APPLICATION OF COMPUTED DENSITOMETRY FOR MONITORING THE RESULTS OF TREATMENT OF PATIENTS ON MONO- AND POLYRESISTANT LUNG TUBERCULOSIS

 

DOI: 10.31215/2306-4927-2018-99-1-59
Î. Â. Õìåëü, ². À. Êàëàáóõà, È. Â. ˳ñê³íà
ÌÎÐÔÎËÎò×Ͳ ÀÑÏÅÊÒÈ ÇÀÑÒÎÑÓÂÀÍÍß Õ²ÐÓÐò×ÍÎÃΠ˲ÊÓÂÀÍÍß Ó ÕÂÎÐÈÕ ÍÀ ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

O. V. Khmel, I. A. Kalabukha, I. V. Liskina
MORPHOLOGICAL ASPECTS OF SURGICAL TREATMENT IN PATIENTS WITH DRUG RESISTANT PULMONARY TUBERCULOSIS

 

 

DOI: 10.31215/2306-4927-2018-99-1-65
Î. Â. Áåëàí, Î. À. Øëèêîâà, Ò. Â. Ìàìîíòîâà, ². Ï. Êàéäàøåâ
ÂÈÇÍÀ×ÅÍÍß ÏÎ˲ÌÎÐÔ²ÇÌÓ PRO12ALA ÃÅÍÀ PPAR-γ2 ßÊ ÏÐÅÄÈÊÒÎÐÀ ÅÔÅÊÒÈÂÍÎÑÒ² ÏÐÎÒÈÇÀÏÀËÜÍί ÒÅÐÀϲ¯ ϲÎÃ˲ÒÀÇÎÍÎÌ ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ ÍÀ ÔÎͲ ²ØÅ̲×Íί ÕÂÎÐÎÁÈ ÑÅÐÖß

®

O. V. Byelan, O. A. Shlykova, Ò. V. Mamontova, I. P. Kaidashev
DETERMINATION OF PRO12ALA POLYMORPHISM OF PPAR-γ2 GENE AS PREDICTOR OF EFFICACY OF PYOGLITAZONE ANTI-INFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN COMBINATION WITH CORONARY HEART DISEASE

 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

ÌÅËÜÍÈÊÓ ÂÀÑÈËÞ ÌÈÕÀÉËÎÂÈ×Ó — 70 !
®

MELNIK V. M. (70 years anniversary)
 

 


HomeÏîøóê Ïðî ³íñòèòóòÍîâèíè Íàø³ âèäàííÿ Îðèã³íàëüí³ ñòàòò³ Íîâîââåäåííÿ
ÏàòåíòèÇâ³òè ïðî ÍÄРϳäãîòîâêà êàäð³â Íàóêîâ³ ôîðóìè 
Iíôîðìàö³ÿ äëÿ ôàõ³âö³â²íôîðìàö³ÿ äëÿ íàñåëåííÿÌåäè÷í³ ïîñëóãè


© ³ää³ë ²ÊÒ
ͲÔÏ

Îòïðàâèòü E-mail â Èíñòèòóò

www.ifp.kiev.ua